RNA Technologies in Cardiovascular Medicine and Research

I. MicroRNA

1. An Overview of MicroRNA
E. Wang

2. MicroRNAs and Their Potential
M. Abdellatif

3. miRNAs and Their Emerging Role in Cardiac Hypertrophy
T. E. Callis, M. Tatsuguchi, D. Z. Wang

4. MicroRNAs and the Control of Heart Pathophysiology
D. Catalucci, M. V. G. Latronico, G. Condorelli

5. MicroRNA Systems Biology
E. Wang

II. RNA Interference

6. Targeting Viral Heart Disease by RNA Interference
S. Merl, R. Wessely

7. Design of siRNAs and shRNAs for RNA Interference: Possible Clinical Applications
V. Pekarik

8. RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders
W. Poller, L. Suckau, S. Pinkert, H. Fechner

9. Cardiac Delivery of Nucleic Acids by Transcriptional and Transductional Targeting of Adeno-Associated Viral Vectors
O. J. Müller, H. A. Katus

III. Ribozymes

10. Characterization of Hammerhead Ribozymes Potentially Suitable for the Treatment of Hyper-Proliferative Vascular Diseases
G. Grassi, M. Grassi

11. Applications of Ribozymes and Pyrrole–Imidazole Polyamides for Cardiovascular and Renal Diseases
E. -H. Yao, N. Fukuda

IV. Noncoding, Aptamer and Antisense RNAs

12. Noncoding RNAs in Human Diseases
M. Szymanski, J. Barciszewski

13. Aptamers and siRNAs in Cardiovascular Disease
C. M. Blake, S. Oney, S. M. Nimjee, B. A. Sullenger

14. Nucleic Acid Aptamers for Cardiovascular Therapeutics
P. S. Pendergrast, K. M. Thompson, R. G. Schaub

15. NF?B Decoy Oligodeoxynucleotide-Based Therapy in Cardiovascular Diseases
H. Nakagami, M. K. Osako, N. Tomita, R. Morishita

16. Antisense Therapy for Restenosis Following Percutaneous Coronary Interventions
N. Kipshidze

17. Toxic RNA in Pathogenesis of Human Neuromuscular Disorders
D. Napierala, M. Napierala

DRM-restrictions

Printing: not available
Clipboard copying: not available

Keywords: TECHNOLOGY & ENGINEERING / Biomedical TEC059000